Revium Rx.

Health Information Services • Healthcare • Herzliya, Israel • RVRC (PNK)

Revium Rx. operates as a pre-clinical stage biopharmaceutical company focused on the development of nanoparticle-based therapies in the United States. The company develops lipid-based platforms for a variety of uses including antimicrobial resistance and solid tumors. The company specializes in infectious diseases, including antibiotic-resistant infections, solid tumors and vaccination. The company also develops nano-liposomal particles (NLP) based pharmaceutical candidates. It develops nanoparticles-based formulation of a potent antibiotic; novel adjuvant for cancer therapies: and novel immunization based on liposomal protein-loaded technology. The company was formerly known as Revium Recovery Inc. and changed its name to Revium Rx. in December 2024. Revium Rx. was founded in 1997 and is based in Herzliya, Israel.

972 1 800 5191687 Azrieli Business Center, Israel

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Revium Rx (RVRC) Completes Acquisition of LipoVation Ltd. - GlobeNewswire

GlobeNewswire • Feb 4

Revium Rx Advances Toward Phase 1 Clinical Development of - GlobeNewswire

GlobeNewswire • Oct 21

Other Health Information Services Companies

View All →

GE Healthcare Technologies Inc.

Frequently Asked Questions

Has Revium Rx. had layoffs?

No layoff events have been recorded for Revium Rx. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Revium Rx. have?

Revium Rx. has approximately 3 employees.

What industry is Revium Rx. in?

Revium Rx. operates in the Health Information Services industry, within the Healthcare sector.

Is Revium Rx. a publicly traded company?

Yes, Revium Rx. is publicly traded under the ticker symbol RVRC on the PNK. The company has a market capitalization of approximately $0.03 billion.

Where is Revium Rx. headquartered?

Revium Rx. is headquartered in Herzliya, Israel at Azrieli Business Center, Israel.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.